newborn screening kuwait
TRANSCRIPT
Newborn Screening: Kuwait’s Expanded Screening
Program
Prepared by: Dr . Amir Abdelazim Ahmed clinical pathology specialist at Kuwait medical Genetic Center
Newborn Screening – What’s new? Previously:
◦ PKU, congenital hypothyroidism
At 31 October 2014 : ◦ Progressive expansion to 22 primary disorders
◦ NBS includes metabolic and endocrine conditions
Expanded NBS – 22 conditions
18 inborn errors of metabolism
2 endocrine disorders ◦ Congenital hypothyroidism
◦ Congenital adrenal hyperplasia
2 other metabolic disorders ◦ Galactosemia
◦ Biotinidase deficiency
Benefits of NBS
Identification
Early intervention
Reduced morbidity & mortality
Family planning
Risks of NBS
Parental anxiety (false positives)
Missed diagnosis (false negatives)
The right ‘not to know’
Unanticipated outcomes
Labelling – diagnosis of benign conditions
NBS: how & where is it done?
Method: Heel prick
Sample collection: newborn screening card collected by staff of each hospital
Testing Location: Newborn Screening laboratory at KMGC
Transportation: NBS cards are sent from all hospitals via special drivers
Timing of Testing Acceptable samples
◦ between 1 day (24 hours) and 7 days after birth
Best time for sample: ◦ between 2 days (48 hours) and 3 days (72 hours) after birth
If tested before 1 day (24 hours) of age,
REPEAT the test within 5 days If the baby is >5 days, screening is still
available ◦ Show Kuwait NS-protocol for details
Special Considerations Prematurity If <33 weeks - collect three specimens at 2,14and 30 days old
◦ Indicate this on NBS card (1st , 2nd , 3rd ) ◦ Premature may have false positive test results
Total Parenteral Nutrition (TPN) ◦ Certain amino acids and organic acids will be elevated ◦ Indicate this on NBS card
Transfusion ◦ Disorders may be missed ◦ Ideally complete card and obtain sample before transfusion
Early discharge ◦ If prior to 24 hours, parents should be informed that a
repeat sample must be done and hospital give him referral for 2nd sample time
The Heel Test
Sample qualitative
validity
NBS Report
Screen Positive Results
Screen positive means: ◦ Further testing is required to confirm the diagnosis
◦ Does NOT mean that the infant is affected
NSO will immediately notify parents and arrange confirmatory testing
If diagnosis is confirmed, cases refere to specialist for treatment & follow up
Report will be mailed to NSO at hospital according to the parent address , provided that correct information is completed on the screening card.
Results of Expanded NBS by MS/MS Schulze et al. Pediatrics 2003
250,000 neonates screened for 23 inborn errors of metabolism ◦ 106 newborns with confirmed metabolic disorder
70 required treatment
◦ Overall prevalence of metabolic disorder = 1/2400 ◦ 825 false positives (0.33% false positive rate) ◦ Overall specificity = 99.67% (PPV = 11.3%) ◦ Overall sensitivity = 100% for classic forms of disorders
= 92.6% for variants
◦ 61 /106 were judged to have benefited from screening and treatment 58% of true positives
1/4100 newborns
Negative Results
Results will go to: ◦ Submitting health care professional/hospital
If you suspect that an infant or child has symptoms of a screened condition and their NBS results are negative – please refer to the appropriate specialist for evaluation
◦ NBS panel does not screen for every metabolic condition
◦ NBS is a screening test – not diagnostic
Expanded NBS – 22 conditions
18 inborn errors of metabolism ◦ 7 organic acid disorders
◦ 5 fatty acid oxidation disorders
◦ 6 amino acid disorders
2 endocrine disorders
2 other metabolic disorders
Inborn errors of metabolism
Rare
Usually autosomal recessive inheritance
◦consanguinity is more common Symptoms secondary to a problem in the
metabolic pathway
Usually not significant dysmorphism
Early recognition and intervention can be lifesaving
Organic Acid Disorders
Isovaleric acidemia (IVA) Glutaric acidemia type 1 (GA1) Multiple carboxylase deficiency (MCD) Methylmalonic acidemia (MMA) 3-methylcrotonyl-CoA carboxylase (3MCC)
deficiency Propionic acidemia (PA) Β-ketothiolase deficiency (BKT)
Organic Acid Disorders
What are organic acid disorders? ◦ Body cannot metabolize certain amino acids and fats ◦ Accumulation of organic acids in blood and urine ◦ Serious potentially preventable effects on health and
development, including death
Symptoms ◦ acute encephalopathy, vomiting, metabolic acidosis,
ketosis, hyperammonemia, hypoglycemia, coma ◦ dehydration, failure to thrive, hypotonia, global
developmental delay ◦ sepsis, death
Treatment ◦ Low protein diet / restrict amino acids, ◦ Supplements: carnitine, biotin, riboflavin, glycine ◦ Avoid fasting
Fatty Acid Oxidation Disorders
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency
Very long-chain acyl-CoA dehydrogenase deficiency (VLCAD)
Long-chain L-3-OH acyl-CoA dehydrogenase deficiency (LCHAD)
Trifunctional protein deficiency (TFP) ◦ catalyzes 3 steps in mitochondrial beta-oxidation of fatty acids
3-Hydroxy-3-methylglutaryl-CoA lyase def.(3HMG)
Disorders of Fatty Acid Oxidation
What are disorders of fatty acid oxidation? ◦ Breakdown of fatty acids in mitochondria is an essential
part of body’s ability to produce energy
◦ Disorder: inability to break down fatty acids
Symptoms ◦ Decompensate with any catabolic stress
fever, fasting, intercurrent illness
◦ Hypoketotic hypoglycemia, liver, muscle, heart disease
◦ Lethargy, seizures, coma, sudden death (SIDS)
Treatment ◦ Avoid fasting
◦ IV glucose when ill to prevent hypoglycemia
◦ Frequent feeding
Amino Acid Disorders
Phenylketonuria (PKU) Maple syrup urine disease (MSUD)
Tyrosinemia type 1 (TYR 1) ◦Common in French Canadians
Homocystinuria (HCY) Citrullinemia (CIT) Argininosuccinic acidemia (ASA)
Amino Acid Disorders
What are amino acid disorders? ◦ Occur when the body cannot either metabolize or
produce certain amino acids
◦ Result in toxic accumulation of substances
◦ Serious potentially preventable effects on health and development including death
Symptoms (untreated) example PKU ◦ Hyperphenylalaninemia (neurotoxic)
◦ Microcephaly, epilepsy, mental retardation, behaviour problems
Treatment ◦ Diet: reduce phenylalanine, low protein, supplement
cofactors or essential amino acids
Expanded NBS – 22 conditions
18 inborn errors of metabolism ◦ 7 organic acid disorders
◦ 5 fatty acid oxidation disorders
◦ 6 amino acid disorders
2 endocrine disorders
2 other metabolic disorders
Endocrine Disorders: CH
Congenital Hypothyroidism (CH)
What is CH? ◦ inadequate thyroid hormone production
◦ Anatomic defect in gland, dyshormogenesis, iodine deficiency
Symptoms ◦ MR, ↓ growth & bone maturation, neurologic problems:
spasticity, gait abn, dysarthria, autistic behaviour
Treatment ◦ Diagnosis made before 13 days to prevent symptoms
◦ Thyroid hormone replacement
Endocrine Disorders: CAH
Congenital Adrenal Hyperplasia (CAH)
What is CAH?
◦ Impaired synthesis of cortisol by the adrenal cortex leads to ↑↑↑ androgen biosynthesis
◦ Inability to maintain adequate energy & blood glucose level to meet stress of injury & illness
Symptoms
◦ Virilization (♀ ambiguous genitalia), precocious puberty, infertility, short stature
◦ Renal salt wasting leads to FTT, vomiting, dehydration, hypotension, hyponatremia, & hyperkalemia
Treatment
◦ Glucocorticoid replacement therapy
Expanded NBS – 22 conditions
18 inborn errors of metabolism ◦ 7 organic acid disorders
◦ 5 fatty acid oxidation disorders
◦ 6 amino acid disorders
2 endocrine disorders
2 other metabolic disorders
Other Disorders: Biotinidase deficiency
What is biotinidase deficiency? ◦ Biotinidase is responsible for recycling biotin – a cofactor for
4 dependant carboxylases
Symptoms ◦ Metabolic ketoacidosis, organic aciduria, mild
hyperammonemia
◦ Seizures, hypotonia, ataxia, developmental delay, vision problems, hearing loss, cutaneous abnormalities
Treatment ◦ 5-10mg of oral biotin per day, long term treatment prevents
all symptoms
Other Disorders: Galactosemia
What is galactosemia? ◦ Lactose is main sugar in breast milk & infant formulas
◦ Metabolized into glucose and galactose in the intestine
◦ Unable to break down galactose
Symptoms ◦ Feeding problems, FTT, bleeding, infection, liver failure,
cataracts, mental retardation, death
Treatment ◦ Lactose-galactose-restricted diet
must be started in first 10 days of life to prevent symptoms
◦ Even with treatment - ↑ developmental delay, speech problems, abn motor function, premature ovarian failure
References Ontario newborn screening guideline protocol National Newborn Screening & Global Resource Center http://genes-r-us.uthscsa.edu/